+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Pompe Disease R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Pompe Disease R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 101 pages
From
From
From
From
From
From
From
From
Sarepta Therapeutics Incorporated - Product Thumbnail Image

Sarepta Therapeutics Incorporated

  • Company Profile
  • September 2021
  • 70 Pages
Loading Indicator
adroll